Results 181 to 190 of about 54,207 (313)
Population Pharmacokinetics of Dasatinib in Healthy Subjects
PharmaceuticalsBackground and Objectives: Dasatinib is one of the tyrosine kinase inhibitors. The main use of these agents is inhibition of cancerous cell proliferation. The therapeutic importance of tyrosine kinase inhibitors raises the necessity of many types of investigations, especially the pharmacokinetic analysis of these drugs in humans.
Walaa B. Hassouneh +3 more
openaire +3 more sources
Inhibition of Src Family Kinases with Dasatinib Blocks Migration and Invasion of Human Melanoma Cells [PDF]
, 2008 Ralf Buettner +4 more
openalex +1 more source
Stromal cell effects on melanoma cell drug response [PDF]
, 2013 Thesis (M.A.)--Boston UniversityObjective: Melanoma is currently one of the deadliest forms of skin disease in the United States. However in the past decade there have been significant advances in treatment.
Della Penna, Greg
core +1 more source
Failure to achieve a major cytogenetic response by 12 months defines inadequate response in patients receiving nilotinib or dasatinib as second or subsequent line therapy for chronic myeloid leukemia [PDF]
, 2008 Constantine S. Tam +7 more
openalex +1 more source
Effects of Dasatinib on Src Kinase Activity and Downstream Intracellular Signaling in Primitive Chronic Myelogenous Leukemia Hematopoietic Cells [PDF]
, 2008 Helmut König +5 more
openalex +1 more source
Dasatinib suppresses in vitro natural killer cell cytotoxicity [PDF]
, 2008 Stephen J. Blake +4 more
openalex +1 more source